On the contrary, LXRα was recently shown to decrease NLRP3 mRNA and protein levels in renal cell carcinomas metastasis in vivo and in vitro, thus resulting in the reduction of pro-IL1β and pro-caspase1 protein levels and the inhibition of IL1β secretion (144). Here, IL1B is linked to hereditary clear cell renal cell carcinoma.